New Pneumococcal vaccine trial is recruiting baby participants

One of the many diseases we routinely vaccinate children against is pneumococcal [noo-muh-KOK-ul] disease, which is caused by over 90 different types of pneumococcal bacteria. Among children, it is the most common bacterial cause of infections of the lungs (pneumonia), brain (meningitis), and blood (bacteraemia).

Children younger than 2 years old are most likely to have a serious case of pneumococcal disease.

The current scheduled pneumococcal vaccine provides protection against 13 types of pneumococcal germs. The Children's Hospital at Westmead is conducting a vaccine research study to evaluate a new vaccine that has the potential to protect against 20 types of pneumococcal bacteria.

This new vaccine contains the same 13 strains as the current vaccine plus 7 extra strains and is made by the same company that makes the current 13 strain vaccine.

If your baby is under 8 weeks of age, you might like to participate in the trial. The study will involve five clinic visits over about 11 months. During this time your baby will receive the routine vaccinations and either the current 13 strain or the new 20 strain pneumococcal vaccine.

A small blood sample (a teaspoon full) will be collected at 5, 11, and 12 months of age.

Your child will receive regular reviews at each visit by a paediatrician. There are no costs associated with participation and participants receive approximately $500 over the course of the study as compensation for travel and time.

Interested or like to find out more?

Contacting us doesn’t mean your baby has to take part, and we would like to assure you that you can change your mind at any time.